secwatch.observer — SEC 8-K summary
======================================

Issuer:     PROKIDNEY CORP. (PROK)
CIK:        0001850270
Form:       8-K
Filed at:   2024-05-29T23:59:59+00:00
Accession:  0001140361-24-027808
Event type: other_material
Sentiment:  neutral
Materiality: 0.50
Item codes: 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

ProKidney provides final Phase 2 RMCL-002 data; specifics not in filing text
----------------------------------------------------------------------------

- Company furnished investor presentation with final data from Phase 2 RMCL-002 clinical trial.
- Presentation available on ProKidney's website; full data not included in 8-K excerpt.
- Trial targets dialysis prevention; efficacy/safety figures not disclosed in filing.
- No financial or operational updates beyond the trial data release.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1850270/000114036124027808/0001140361-24-027808-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1850270/000114036124027808/ef20030179_8k.htm
  HTML page:      https://secwatch.observer/filing/0001140361-24-027808

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer